FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 62 filers reported holding FORTRESS BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $99,000 | +13.8% | 38,493 | -37.5% | 0.01% | +25.0% |
| Q3 2019 | $87,000 | +55.4% | 61,571 | +63.7% | 0.00% | +33.3% |
| Q2 2019 | $56,000 | +409.1% | 37,620 | +205.2% | 0.00% | +200.0% |
| Q4 2018 | $11,000 | -71.8% | 12,327 | -50.6% | 0.00% | -50.0% |
| Q3 2018 | $39,000 | -46.6% | 24,958 | +1.5% | 0.00% | -33.3% |
| Q2 2018 | $73,000 | +12.3% | 24,579 | +69.5% | 0.00% | 0.0% |
| Q1 2018 | $65,000 | -36.9% | 14,499 | -44.0% | 0.00% | -40.0% |
| Q4 2017 | $103,000 | – | 25,899 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |